SILVER SPRING, Maryland (Reuters) - Experimental obesity drug Qnexa won the backing of U.S. health advisors on Wednesday, raising hopes for approval of the first prescription weight-loss pill in 13 years.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/VMozou5ZpbQ/us-fda-obesity-vivus-idUSTRE81L2AS20120223
save money travel make money best news online money internet business
No comments:
Post a Comment